Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06336642 · ClinicalTrials.gov registry record · Phase 2

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

A Phase 2 study of Dyspnea, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
Phase 2
Development phase
150
Enrollment target
1
Study location

NCT06336642 is a Phase 2 study of Dyspnea that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 150 participants, below the 299-participant average among 23 other Dyspnea trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06336642, a Phase 2 study of Dyspnea, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
Phase 2
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.

Conditions Studied

Dyspnea

Interventions

  • BEHAVIORAL SPOT-ON Early Start
  • BEHAVIORAL SPOT-ON Delayed Start

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-06-11
Est. Completion 2032-03-31
Phase Phase 2

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06336642

The ClinicalTrials.gov registry entry for NCT06336642 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 299-participant average among 23 other Dyspnea trials with a reported enrollment target (50% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dyspnea appearing as the primary indexed condition, and to 2 interventions - of which SPOT-ON Early Start is the first listed.

NCT06336642 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06336642 about?

NCT06336642 is a clinical study titled "Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology". To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.

What is the current status of trial NCT06336642?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2024-06-11. Estimated completion is 2032-03-31.

What conditions does trial NCT06336642 study?

This clinical trial studies the following conditions: Dyspnea.

What interventions are being tested in trial NCT06336642?

The interventions under investigation include: SPOT-ON Early Start (BEHAVIORAL), SPOT-ON Delayed Start (BEHAVIORAL).

Who is sponsoring clinical trial NCT06336642?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06336642 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dyspnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dyspnea

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.